Beta-agonist Efficacy and Tolerability as Adjuvant Therapy in Myasthenia Gravis
Status:
Recruiting
Trial end date:
2021-10-31
Target enrollment:
Participant gender:
Summary
This study examines the effect of adjuvant therapy with the oral beta-agonist Salbutamol in
patients with generalized myasthenia gravis on stable standard of care having residual
symptoms.